Access cutting-edge cerebral autosomal dominant ateriopathy with subcortical infarcts and leukoencephalopathy treatment through this clinical trial at a research site in Madison. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Madison location
Preparing your pre-screening questions…
Access cerebral autosomal dominant ateriopathy with subcortical infarcts and leukoencephalopathy specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cerebral autosomal dominant ateriopathy with subcortical infarcts and leukoencephalopathy treatment provided free
Check if you qualify for this cerebral autosomal dominant ateriopathy with subcortical infarcts and leukoencephalopathy clinical trial in Madison, WI
No-Cost Study Care
Local to Madison
Convenient for WI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is being done in order to create a registry (list) of people interested in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) research. It may be that you have a family member or other loved one with CADASIL, or that you may have CADASIL or are at risk. Participation means that your name will be added to a list of people who will be invited to participate in future research studies on CADASIL. Participants must be 18 years or older, and will remain on the registry until they request to be removed.
Sponsor: University of Wisconsin, Madison
Yes, this clinical trial (NCT05567744) has an active research site in Madison, WI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for cerebral autosomal dominant ateriopathy with subcortical infarcts and leukoencephalopathy treatment options in Madison, WI, this clinical trial (NCT05567744) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Madison research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cerebral autosomal dominant ateriopathy with subcortical infarcts and leukoencephalopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all cerebral autosomal dominant ateriopathy with subcortical infarcts and leukoencephalopathy clinical trials near you to find additional studies recruiting in your area.
See all heart attack clinical trials recruiting in Madison — not just this study.
Browse Heart Attack Trials in Madison →